Caso, Eddie A.
HRN: 21-52-62 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/06/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/06/2022
07/13/2022
IV
500mg
Q8
Incarcerated Indirect Inguinal Hernia
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Skin & Soft TissueIntra-abdominal Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes